Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PharmaEssentia | Taiwan | Healthcare | Biotechnology & Medical Research | NT$166.36B | 43.3x | 0.06 | NT$515 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.7% Upside | Upgrade to Pro+ | |
Polaris Group | Taiwan | Healthcare | Biotechnology & Medical Research | NT$31.97B | -11.9x | 0.19 | NT$39.80 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lumosa Therapeutics | TPEX | Healthcare | Biotechnology & Medical Research | NT$27.18B | -62.3x | -3.73 | NT$161 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42.9% Upside | Upgrade to Pro+ | |
Sunmax BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$22.22B | 30.6x | 3.96 | NT$408 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TaiMed Biologics | TPEX | Healthcare | Biotechnology & Medical Research | NT$20.84B | -99.1x | 2 | NT$76.30 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gongwin Biopharm | TPEX | Healthcare | Biotechnology & Medical Research | NT$14.37B | -207.3x | -5.26 | NT$114 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PharmaEngine | TPEX | Healthcare | Biotechnology & Medical Research | NT$12.92B | 7.3x | 0.01 | NT$89.90 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.5% Upside | Upgrade to Pro+ | |
Tanvex BioPharma | Taiwan | Healthcare | Biotechnology & Medical Research | NT$12.81B | -0.21 | NT$54.20 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Foresee Pharmas | TPEX | Healthcare | Biotechnology & Medical Research | NT$9.98B | -7.3x | 0.42 | NT$64.50 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OBI Pharma | TPEX | Healthcare | Biotechnology & Medical Research | NT$8.90B | -3.6x | 0.05 | NT$33.85 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mycenax Biotech | TPEX | Healthcare | Biotechnology & Medical Research | NT$7.91B | -17.1x | -0.87 | NT$38.20 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medigen BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$4.40B | -166.1x | -1.75 | NT$31.55 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SINEW Pharma | TPEX | Healthcare | Biotechnology & Medical Research | NT$3.58B | -23.8x | -1.79 | NT$50.20 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bionet | TPEX | Healthcare | Biotechnology & Medical Research | NT$3.55B | 46.2x | -36.28 | NT$69.80 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Senhwa Biosciences | TPEX | Healthcare | Biotechnology & Medical Research | NT$3.11B | -10.6x | 5.43 | NT$34.90 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TaiRx | TPEX | Healthcare | Biotechnology & Medical Research | NT$2.66B | -19x | -0.63 | NT$24 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GlycoNex | TPEX | Healthcare | Biotechnology & Medical Research | NT$2.42B | -13.2x | 2.14 | NT$22.35 | 9.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Golden BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$2.26B | -5.6x | -1.03 | NT$13.95 | 4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Applied BioCode | Taiwan | Healthcare | Biotechnology & Medical Research | NT$2.19B | -8.2x | 0.68 | NT$21.15 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abnova | Taiwan | Healthcare | Biotechnology & Medical Research | NT$1.85B | 38.9x | -1.98 | NT$31 | 3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dv Biomed | TPEX | Healthcare | Biotechnology & Medical Research | NT$1.56B | 17.3x | -0.42 | NT$75.50 | -5.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genesis Genetics Asia | TPEX | Healthcare | Biotechnology & Medical Research | NT$1.43B | 29.7x | 0.83 | NT$53.70 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genomics BioSci &Tech | TPEX | Healthcare | Biotechnology & Medical Research | NT$1.34B | -6x | 0.2 | NT$18.45 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Taiwan Advance Bio-Pharma | TPEX | Healthcare | Biotechnology & Medical Research | NT$1.26B | 56.2x | 0.18 | NT$14.05 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kim Forest Enterprise | Taiwan | Healthcare | Biotechnology & Medical Research | NT$1.23B | -6.6x | 0.56 | NT$20.20 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Inalways | TPEX | Healthcare | Biotechnology & Medical Research | NT$1.05B | -2,130x | -14.94 | NT$21.30 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SynCore BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$1.02B | -18.7x | 0.22 | NT$29 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Twi BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$933.25M | -6.1x | -0.3 | NT$10.65 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BioLASCO Taiwan | TPEX | Healthcare | Biotechnology & Medical Research | NT$868.25M | 19.5x | -5.07 | NT$33.90 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sofiva Genomics | TPEX | Healthcare | Biotechnology & Medical Research | NT$715.82M | 269.7x | -3.07 | NT$33.15 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TaiwanJ Pharmas | TPEX | Healthcare | Biotechnology & Medical Research | NT$619.34M | -26.7x | 0.11 | NT$7.73 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Welgene Biotech | TPEX | Healthcare | Biotechnology & Medical Research | NT$505.70M | 228.8x | 1.34 | NT$21.70 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |